- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Preventing Unnecessary Hospital Readmissions
David May, MD, PhD, FACC, secretary of the American College of Cardiology and managing partner of Cardiovascular Specialists in Dallas, Texas, discusses transitions of care strategies that healthcare professionals should consider to help improve patient outcomes and reduce the burden of unnecessary hospital readmissions.
Dr May explains how hospital readmissions are costly in clinical and economic terms, and notes that many cardiology-related hospital readmissions are potentially preventable.
Although unanticipated issues may arise during transitions between levels of care, Dr May suggests that educating the patient and his or her family about the challenges that are likely to occur can help mitigate their need to seek further medical assistance.
Dr May discusses how scheduling doctors’ visits within the first 7 days following discharge is likely to comfort patients and lower the rate of unnecessary readmissions to hospitals or visits to more expensive sources of care.
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Lp(a) and Getting a Head Start Against Heart Disease: Jeremy Wigginton, MD
April 8th 2025Lipoprotein a (Lp[a]) is a valuable tool for assessing a patient's risk of cardiovascular disease, which can facilitate earlier intervention efforts and reduce health care costs, argued Jeremy Wigginton, MD.
Read More
